Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes | Patent Publication Number 20040220144

US 20040220144 A1
Patent NumberUS 07189740 B2
Application Number10411649
Filled DateApr 11, 2003
Priority DateOct 15, 2002
Publication DateNov 4, 2004
Original AssigneeBristol Myers Squibb
Current AssigneeCelgene
Inventor/ApplicantsJerome B. Zeldis
Jerome B. Zeldis
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.